Date: 05 May, 2022
INAM, the Innovation Network for Advanced Materials announces Sumatrix Biotech as an ADMACOM 2022 finalist. Alongside 10 other startups, Sumatrix Biotech, joins the 8th edition of the Advanced Materials accelerator program, ADMACOM.
Sumatrix Biotech repurposes industrial waste into bioactive and sustainable biocellulose-based products. Sumatrix Biotech isolates glucose from industrial waste and converts it into ultra-pure biocellulose hydrogels via biotechnological fermentation. They develop innovative biocellulose hydrogel-based value-creating biomaterials for wound care, medical devices, tissue engineering and industrial applications.
What’s new and innovative:
Instead of conventional Hestrin and Schramm (HS) or fermented coconut fruit extract dependent production, that are nearly 90% of the bill, Sumatrix’sformulation decreases related expenses dramatically and increases product yield. Sumatrix Biotech offers a much better way to grow biocellulose with affordable, bioactive compounds and superior water holding capacity.
INAM, the Innovation Network for Advanced Materials, is a global network of companies and research institutes in the field of Advanced Materials. INAM’s goal is to enable the right connections and make technological innovations become reality by working closely with startups, SMEs, corporations, investors, and research institutes to start, grow and transform the development of Advanced Materials.
For more information visit: https://www.inam.berlin/
For regular updates on INAM, follow our LinkedIn page.